Aura Biosciences (AURA) Short Interest Ratio & Short Volume

Short interest is the volume of Aura Biosciences shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 2,450,000 shares of AURA short. 6.17% of Aura Biosciences' shares are currently sold short. Learn More on Aura Biosciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AURA shares currently have a short interest ratio of 14.0. Learn More on Aura Biosciences's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aura Biosciences: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.17% of Aura Biosciences' floating shares are currently sold short.

Aura Biosciences saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 2,450,000 shares, an increase of 9.4% from the previous total of 2,240,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Aura Biosciences currently has issued a total of 49,500,000 shares. Some of Aura Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aura Biosciences currently has a public float of 39,710,000 shares.

6.17% of Aura Biosciences' shares are currently sold short. Here is how the short interest of companies compare to Aura Biosciences: Caribou Biosciences, Inc. (12.85%), Tenaya Therapeutics, Inc. (4.99%), TScan Therapeutics, Inc. (0.60%), Solid Biosciences Inc. (3.05%), UroGen Pharma Ltd. (17.87%), Adaptive Biotechnologies Co. (6.57%), Jasper Therapeutics, Inc. (3.84%), SOPHiA GENETICS SA (0.11%), Tourmaline Bio, Inc. (9.57%), Ocugen, Inc. (16.90%),

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

Short selling AURA is an investing strategy that aims to generate trading profit from Aura Biosciences as its price is falling. AURA shares are trading down $0.20 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Aura Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AURA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AURA, twice per month. The most recent reporting period available is March, 31 2024.